These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27994439)
1. Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study. Moschos MM; Nitoda E; Chatziralli IP; Panos GD; Demopoulos CA Drug Des Devel Ther; 2016; 10():3977-3981. PubMed ID: 27994439 [TBL] [Abstract][Full Text] [Related]
2. In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its Metabolism. Moschos MM; Chatziralli IP; Stamatakis G; Papakonstantinou VD; Tsatsos M; Demopoulos CA Semin Ophthalmol; 2017; 32(2):198-203. PubMed ID: 26270771 [TBL] [Abstract][Full Text] [Related]
3. Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets. Moschos MM; Moustafa GA; Papakonstantinou VD; Tsatsos M; Laios K; Antonopoulou S Drug Des Devel Ther; 2017; 11():1267-1272. PubMed ID: 28458520 [TBL] [Abstract][Full Text] [Related]
4. The effect of inhibitors of platelet aggregation on the metabolism of platelet-activating factor (PAF) in washed rabbit platelets. O'Neill C; Ammit AJ; Korth R; Fleming S; Wells X Lipids; 1991 Dec; 26(12):1011-4. PubMed ID: 1726442 [TBL] [Abstract][Full Text] [Related]
5. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial. Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217 [TBL] [Abstract][Full Text] [Related]
6. Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases. Yamada H; Yoneda M; Gosho M; Kato T; Zako M BMC Ophthalmol; 2016 Mar; 16():26. PubMed ID: 26956170 [TBL] [Abstract][Full Text] [Related]
7. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients. Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
9. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets]. Muzia GI; Kulikov VI Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603 [TBL] [Abstract][Full Text] [Related]
10. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation. Kulikov VI; Muzya GI Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178 [TBL] [Abstract][Full Text] [Related]
11. Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits. Giannico AT; Lima L; Shaw GC; Russ HH; Froes TR; Montiani-Ferreira F Arq Bras Oftalmol; 2016 Feb; 79(1):33-6. PubMed ID: 26840164 [TBL] [Abstract][Full Text] [Related]
12. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation. Zhang M; Zhang LZ; Lu JS Zhongguo Yao Li Xue Bao; 1995 May; 16(3):209-12. PubMed ID: 7660812 [TBL] [Abstract][Full Text] [Related]
13. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding. Bin Z; Kun L Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet activity of some prenylflavonoids. Lin CN; Shieh WL; Ko FN; Teng CM Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. Herbert JM; Laplace MC; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Koch E Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702 [TBL] [Abstract][Full Text] [Related]
17. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936 [TBL] [Abstract][Full Text] [Related]
18. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits. Giannico AT; Lima L; Russ HH; Montiani-Ferreira F J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234 [TBL] [Abstract][Full Text] [Related]
19. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661. Komuro Y; Imanishi N; Uchida M; Morooka S Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227 [TBL] [Abstract][Full Text] [Related]
20. Effect of synthetic phospholipids on platelet aggregation and serotonin release. Söling U; Eibl H; Nagel GA; Unger C Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]